MindWalk Announces Results of 2026 Annual General Meeting of Shareholders
Dr. Jennifer Bath, Jon Lieber and Kim Remizowski elected to the Board of Directors; Davidson & Company LLP re-appointed as auditor; Dirk Witters tenders resignation under the Company’s Majority Voting Policy
AUSTIN, Texas–(BUSINESS WIRE)–
MindWalk Holdings Corp. (“MindWalk” or the “Company”) (NASDAQ: HYFT), a Bio-Native AI company, today announced the voting results of its 2026 Annual General Meeting of Shareholders held on November 17, 2026. A total of 18,619,753 common shares were represented by proxy at the meeting, representing 39.13% of the 47,574,512 common shares issued and outstanding as of the October 13, 2026 record date.
Shareholders elected Dr. Jennifer L. Bath, Jon Lieber and Kim Remizowski to the Company’s Board of Directors, each to hold office until the next annual meeting of shareholders or until a successor is duly elected or appointed. Detailed results of the vote on the election of directors are set out below.
|
Nominee |
Votes For |
% For |
Votes Withheld |
% Withheld |
|
Dr. Jennifer L. Bath |
14,164,166 |
83.42% |
2,814,496 |
16.57% |
|
Jon Lieber |
10,012,476 |
58.97% |
6,966,187 |
41.02% |
|
Kim Remizowski |
16,085,630 |
94.74% |
893,032 |
5.25% |
|
Dirk Witters |
5,419,936 |
31.92% |
11,558,727 |
68.07% |
Dirk Witters received 31.92% of the votes cast in favor of his re-election and, in accordance with the Company’s Majority Voting Policy, tendered his resignation to the Board. The Board has accepted Mr. Witters’ resignation, effective immediately, and thanks him for his contributions to MindWalk during his service as a director.
The Board has initiated a process to identify a successor to fill the resulting vacancy, consistent with the Company’s governance framework, and will provide an update once an appointment has been made.
Shareholders also re-appointed Davidson & Company LLP as the Company’s auditor to hold office until the next annual meeting of shareholders, with 17,843,543 votes (95.83%) cast for and 776,209 votes (4.16%) cast against the resolution.
The Company will file a report of voting results on SEDAR+ and furnish it to the U.S. Securities and Exchange Commission on Form 6-K.
About MindWalk Holdings Corp.
MindWalk Holdings Corp. (NASDAQ: HYFT) is a Bio-Native AI company building the BioIntelligence infrastructure that life sciences AI and agentic AI require, integrating AI, data, and advanced wet lab capabilities into one connected discovery ecosystem. At its core is HYFT® Technology, a proprietary, function-aware representation of biology. Its HYFT fingerprints span sequence and structural biology and, refined over 20 years of curation, form a continuously evolving biological representation of 660 million patterns and 25 billion relationships. This enriched biological representation is the architecture behind ReefIQ™, the biological data substrate that provides context for life sciences, enriching data at ingestion and growing more valuable with each program run on it, and LensAI™, the reasoning and application layer for target discovery, candidate diligence, portfolio decision support, and the agentic AI workflows pharma is racing to deploy. By design, value compounds in this HYFT representation layer, not in any individual AI model that runs on top of it.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of applicable United States and Canadian securities laws, including statements regarding the Board’s process to identify and appoint a successor director, the timing of any such appointment, and the filing of the Company’s report of voting results. Forward-looking statements are based on management’s current expectations and assumptions and are subject to known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially, including: the Company’s ability to identify, attract and appoint a qualified director on the timetable it currently anticipates, or at all; the risk that a director resigns, is not re-elected, or is unable to serve; the Company’s ability to maintain compliance with Nasdaq listing standards, including director independence and committee composition requirements; the Company’s ability to attract and retain qualified independent directors; the pace of commercial adoption of ReefIQ™ and LensAI™; intellectual property risks; competition; regulatory determinations; and capital markets, economic, and geopolitical conditions. Additional information about these and other risks is available under “Risk Factors” in MindWalk’s most recent Annual Report on Form 20-F and other filings on SEDAR+ (sedarplus.ca) and EDGAR (sec.gov/edgar). Except as required by law, MindWalk undertakes no obligation to update any forward-looking statement. Nothing in this press release constitutes investment advice. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities.
Trademarks
HYFT® is a registered trademark of MindWalk Holdings Corp. LensAI™ and ReefIQ™ are trademarks of MindWalk Holdings Corp. or its subsidiaries; ReefIQ™ registration is pending. All other trademarks are the property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261118371061/en/
Investor Relations Contact
Louie Toma, CPA, CFA
Managing Director, CoreIR
[email protected]
KEYWORDS: United States North America Canada Texas
INDUSTRY KEYWORDS: Technology Research Infectious Diseases Health Technology Biotechnology Health Pharmaceutical Science Artificial Intelligence
MEDIA:
| Logo |
![]() |

